European Parliament's Health Committee meets with Commissioner Verheugen

23 February 2009

The European Federation of Pharmaceutical Industries and Associations, which represents the research-based drugmakers in Europe, has called on  the European Parliament "to make the Commission's proposals for safe,  innovative and accessible medicines for European citizens a priority."  The group's statement appeared on the day that Enterprise and Industry  Commissioner Gunter Verheugen was due to meet with the Parliament's  Health Committee for initial exchanges on the recently-launched  Pharmaceutical Package (Marketletter December 15, 2008).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight